We were able to establish a patient-derived xenograft model with confirmed basal phenotype based on positive KRT-5 expression (Figure 2a, top panel) with mosaic expression of ROR1 in cancer cells (Figure 2a, bottom panel). This evidence concerns the gene KRT5 and cancer.